APYX
Apyx Medical Inc
3.00$
+0.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 33.4% | 72.3% | 41.9% | 76.9% | 39.5% | 37.0% | 39.9% | 37.7% | 35.6% | 110.5% | 62.6% | 36.1% | 66.1% | |
| 66.6% | 27.7% | 58.1% | 23.1% | 60.5% | 63.0% | 60.1% | 62.3% | 64.4% | -10.5% | 37.4% | 63.9% | 33.9% | |
| 11.8% | 8.5% | 13.6% | 11.7% | 9.9% | 7.9% | 8.5% | 7.2% | 6.2% | 4.9% | 6.1% | 5.7% | 5.7% | |
| 93.6% | 91.8% | 109.0% | 95.6% | 82.2% | 76.6% | 83.9% | 77.7% | 11.5% | 57.6% | 64.6% | 71.2% | 52.2% | |
| 105.3% | 67.1% | 122.6% | 68.8% | 92.2% | 84.5% | 92.4% | 84.9% | 70.9% | -10.6% | 44.7% | 76.9% | 40.0% | |
| -38.7% | -39.4% | -64.6% | -45.7% | -31.6% | -21.4% | -32.4% | -22.6% | -6.5% | 0.1% | -7.3% | -13.0% | -6.1% | |
| 4.9% | 7.6% | 13.6% | 11.7% | 12.5% | 11.6% | 14.6% | 12.2% | 11.0% | 7.3% | 11.0% | 10.0% | 9.6% | |
| -41.7% | -65.0% | -73.6% | -53.8% | -40.6% | -32.1% | -43.7% | -32.4% | -14.6% | -6.0% | -16.0% | -21.2% | -13.6% | |
| -2.7% | 0.6% | 0.5% | 0.4% | 0.5% | 0.6% | 0.5% | 0.4% | 0.6% | 0.5% | 1.1% | 0.9% | 0.8% | |
| -38.7% | -65.5% | -74.0% | -54.0% | -40.9% | -32.5% | -44.0% | -33.2% | -15.4% | -6.8% | -16.9% | -23.4% | -14.8% | |
| -35.3% | -56.4% | -58.4% | -40.8% | -26.9% | -19.5% | -27.7% | -19.0% | -2.6% | 2.5% | -3.4% | -9.8% | -2.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.